These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1715833)

  • 41. Utility of hepatitis C virus RNA levels for predicting the therapeutic efficacy of interferon.
    Kato J; Komatsu M; Ono T; Ishii T; Hoshino T; Toyoshima I; Chiba M; Masamune O
    J Clin Gastroenterol; 1997 Oct; 25(3):525-8. PubMed ID: 9412970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels.
    Romeo R; Thiers V; Driss F; Berthelot P; Nalpas B; Brechot C
    Transfusion; 1993 Aug; 33(8):629-33. PubMed ID: 7688157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
    Lai ME; Mazzoleni AP; Farci P; Melis A; Porru A; Orgiana G; Arnone M; Balestrieri A
    J Med Virol; 1993 Dec; 41(4):282-8. PubMed ID: 7508972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels.
    Garcia-Valdecasas J; Bernal C; Cerezo S; Garcia F; Montiel N; Leyva A; Umana WO; Bosch JP
    ASAIO J; 1994; 40(3):M450-3. PubMed ID: 8555556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Choice of appropriate end points of response to interferon therapy in chronic hepatitis C virus infection.
    Davis GL; Lau JY
    J Hepatol; 1995; 22(1 Suppl):110-4. PubMed ID: 7602061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels.
    Puoti C; Magrini A; Stati T; Rigato P; Montagnese F; Rossi P; Aldegheri L; Resta S
    Hepatology; 1997 Dec; 26(6):1393-8. PubMed ID: 9397976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes of serum hepatitis C virus levels in patients with chronic hepatitis C treated with two courses of interferon administration.
    Saitoh Y; Miura M; Niitsuma H; Numata N; Ohori H; Ishii M; Toyota T
    Tohoku J Exp Med; 1994 Aug; 173(4):361-9. PubMed ID: 7529950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Outcome of the cases of chronic liver disease type C who exhibited long term response to interferon therapy; comparison of the cases with or without serum HCV-RNA].
    Tohyama H; Iwabuchi S; Takatori M
    Nihon Shokakibyo Gakkai Zasshi; 1996 Nov; 93(11):813-20. PubMed ID: 8953921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.
    Martinot-Peignoux M; Boyer N; Cazals-Hatem D; Pham BN; Gervais A; Le Breton V; Levy S; Degott C; Valla DC; Marcellin P
    Hepatology; 2001 Nov; 34(5):1000-5. PubMed ID: 11679971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection.
    Ghany MG; Chan TM; Sanchez-Pescador R; Urdea M; Lok AS
    Dig Dis Sci; 1996 Nov; 41(11):2213-8. PubMed ID: 8943974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamics of alanine aminotransferase during hepatitis C virus treatment.
    Ribeiro RM; Layden-Almer J; Powers KA; Layden TJ; Perelson AS
    Hepatology; 2003 Aug; 38(2):509-17. PubMed ID: 12883496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High sustained response to daily dosing of interferon with ribavirin in chronic hepatitis C patients naïve to therapy.
    Abbas Z; Hamid S; Tabassum S
    J Gastroenterol Hepatol; 2002 May; 17(5):577-81. PubMed ID: 12084032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
    Suzuki T; Tanaka E; Matsumoto A; Urushihara A; Sodeyama T
    J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison.
    Tong MJ; Blatt LM; McHutchison JG; Co RL; Conrad A
    Hepatology; 1997 Dec; 26(6):1640-5. PubMed ID: 9398010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized controlled trial of recombinant interferon-alpha 2b in the treatment of Chinese patients with chronic hepatitis C.
    Hwang SJ; Chan CY; Lu RH; Wu JC; Lee SD
    J Interferon Cytokine Res; 1995 Jul; 15(7):611-6. PubMed ID: 7553231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
    Pawlotsky JM; Roudot-Thoraval F; Muerhoff AS; Pellerin M; Germanidis G; Desai SM; Bastie A; Darthuy F; Rémiré J; Zafrani ES; Soussy CJ; Mushahwar IK; Dhumeaux D
    J Med Virol; 1998 Jan; 54(1):26-37. PubMed ID: 9443106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
    Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of ursodeoxycholic acid in combination with interferon-alpha in treating chronic hepatitis C: results of a long-term follow-up trial.
    Tanaka K; Kondo M; Sakaguchi T; Saito S; Arata S; Ikeda M; Kitamura T; Morimoto M; Sekihara H
    J Gastroenterol Hepatol; 1996 Dec; 11(12):1155-60. PubMed ID: 9034935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.